by Sean Yao | Aug 28, 2024 | News
Agreement Awarded by DARPA in partnership with the Administration for Strategic Preparedness and Response’s (ASPR) Center of Industrial Base Management and Supply Chain (IBMSC) Kannapolis, NC / College Station, Tx August 28, 2024 – Bright Path Laboratories, Inc., a...
by Sean Yao | Feb 29, 2024 | News
On Rare Disease Day 2024, Bright Path Laboratories shared an amazing step in our commitment to rare diseases. Bright Path successfully completed the development of Amlexanox as a potential treatment for WOREE Syndrome, a devastating rare disease that affects children...
by Sean Yao | Dec 13, 2023 | News
KANNAPOLIS, N.C., Dec. 13, 2023 /PRNewswire/ — Bright Path Laboratories, a US-based advanced drug development and manufacturing company is proud to announce their contribution to solving drug shortages for the domestic development and manufacturing of two...
by Sean Yao | Dec 11, 2023 | Uncategorized
Supply Chain Crisis in America Our nation’s over-dependence on foreign pharmaceutical production has left America vulnerable. The Covid-19 pandemic revealed that the U.S. is dangerously exposed to supply chain disruptions. Our limited domestic manufacturing...
by Sean Yao | Aug 11, 2023 | Uncategorized
Capstone Health Alliance and Bright Path Laboratories Enter Into Agreement To Address Drug Shortages Learn More About...
